A.A. Sinkula

592 total citations
9 papers, 437 citations indexed

About

A.A. Sinkula is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, A.A. Sinkula has authored 9 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in A.A. Sinkula's work include Chemical Synthesis and Analysis (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Cancer therapeutics and mechanisms (2 papers). A.A. Sinkula is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Cancer therapeutics and mechanisms (2 papers). A.A. Sinkula collaborates with scholars based in United States. A.A. Sinkula's co-authors include Samuel H. Yalkowsky, Shri C. Valvani, C. J. Lewis, W. Morozowich, Forrest A. MacKellar, Paul E. Schurr and Jack E. Gray and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Pharmaceutical Sciences and Toxicology and Applied Pharmacology.

In The Last Decade

A.A. Sinkula

9 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.A. Sinkula United States 7 155 131 90 88 66 9 437
Paul N. Craig United States 12 338 2.2× 221 1.7× 94 1.0× 71 0.8× 119 1.8× 34 603
Teng‐Man Chen United States 10 81 0.5× 183 1.4× 112 1.2× 187 2.1× 76 1.2× 23 535
Ian Whitcombe United Kingdom 11 131 0.8× 255 1.9× 37 0.4× 100 1.1× 49 0.7× 17 517
C. Hänsch Germany 7 122 0.8× 143 1.1× 44 0.5× 96 1.1× 87 1.3× 16 404
Hidetoshi Ushio Japan 9 62 0.4× 210 1.6× 88 1.0× 123 1.4× 78 1.2× 23 556
Nicholas M. Bonham Sweden 4 150 1.0× 237 1.8× 114 1.3× 116 1.3× 154 2.3× 5 618
Nigel P. Gensmantel United Kingdom 12 153 1.0× 242 1.8× 66 0.7× 60 0.7× 24 0.4× 19 518
Greg M. Pearl United States 11 146 0.9× 155 1.2× 36 0.4× 175 2.0× 161 2.4× 13 574
Hans Peter Cordes Germany 8 85 0.5× 205 1.6× 24 0.3× 57 0.6× 42 0.6× 10 376
J S Kasher United States 8 107 0.7× 203 1.5× 29 0.3× 122 1.4× 47 0.7× 11 410

Countries citing papers authored by A.A. Sinkula

Since Specialization
Citations

This map shows the geographic impact of A.A. Sinkula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.A. Sinkula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.A. Sinkula more than expected).

Fields of papers citing papers by A.A. Sinkula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.A. Sinkula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.A. Sinkula. The network helps show where A.A. Sinkula may publish in the future.

Co-authorship network of co-authors of A.A. Sinkula

This figure shows the co-authorship network connecting the top 25 collaborators of A.A. Sinkula. A scholar is included among the top collaborators of A.A. Sinkula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.A. Sinkula. A.A. Sinkula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Sinkula, A.A.. (1987). Some Perspectives on Targeted Delivery with Prodrugs. Annals of the New York Academy of Sciences. 507(1). 281–288. 3 indexed citations
2.
Yalkowsky, Samuel H., A.A. Sinkula, & Shri C. Valvani. (1980). Physical chemical properties of drugs. M. Dekker eBooks. 208 indexed citations
3.
Sinkula, A.A. & Samuel H. Yalkowsky. (1975). Rationale for Design of Biologically Reversible Drug Derivatives: Prodrugs. Journal of Pharmaceutical Sciences. 64(2). 181–210. 169 indexed citations
4.
Gray, Jack E., et al.. (1974). Drug-induced enteropathy characterized by lipid in macrophages. Toxicology and Applied Pharmacology. 27(1). 145–157. 2 indexed citations
5.
Sinkula, A.A.. (1974). Chemical Modification of Erythromycin: Synthesis and Preliminary Bioactivity of Selected Amides and Esters. Journal of Pharmaceutical Sciences. 63(6). 842–848. 8 indexed citations
6.
Sinkula, A.A. & C. J. Lewis. (1973). Chemical Modification of Lincomycin: Synthesis and Bioactivity of Selected 2,7-Dialkylcarbonate Esters. Journal of Pharmaceutical Sciences. 62(11). 1757–1760. 11 indexed citations
7.
Sinkula, A.A., et al.. (1973). Chemical Modification of Clindamycin: Synthesis and Evaluation of Selected Esters. Journal of Pharmaceutical Sciences. 62(7). 1106–1111. 16 indexed citations
8.
Morozowich, W., A.A. Sinkula, Forrest A. MacKellar, & C. J. Lewis. (1973). Synthesis and Bioactivity of Lincomycin 2-Monoesters. Journal of Pharmaceutical Sciences. 62(7). 1102–1105. 8 indexed citations
9.
Sinkula, A.A., W. Morozowich, C. J. Lewis, & Forrest A. MacKellar. (1969). Synthesis and Bioactivity of Lincomycin-7-Monoesters. Journal of Pharmaceutical Sciences. 58(11). 1389–1392. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026